23.09.2016

ARS will do several bioequivalence + marketing authorization projects for a leading Indian pharmaceutical company. The portfolio will consist of such generics as Telmisartan, Temozolomide, Olmesartan, Etoricoxib, Rosuvastatin, Aripiprazole, Donepezil HCL, and Abiraterone.